
ACHC
USDAcadia Healthcare Company Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$22.580
最高价
$22.701
最低价
$22.110
成交量
1.14M
公司基本面
市值
2.0B
所属行业
Medical Care Facilities
国家/地区
United States
交易统计
平均成交量
2.53M
交易所
NMS
货币
USD
52周价格范围
AI分析报告
最后更新: 2025年5月25日ACHC: Acadia Healthcare Company Inc. Common Stock – Navigating Recent Shifts
Stock Symbol: ACHC Generate Date: 2025-05-25 20:17:03
Let's break down what's been happening with Acadia Healthcare and what the numbers might be telling us.
The Latest Buzz: Analyst Price Target Cuts
Recent news for Acadia Healthcare has a pretty consistent theme: analysts are trimming their price targets. We saw Mizuho drop its target from $37 to $32, Barclays cut theirs from $35 to $28, and even Keybanc, which still rates the stock "Overweight," lowered its target from $65 to $55.
What does this mean? Well, it suggests that while some analysts still see potential, they're generally becoming a bit less optimistic about the stock's near-term upside. It's not a full-blown negative sentiment, but it's certainly a cautious one, leaning towards a "hold" or "neutral" stance from a few key players.
Checking the Price Action: A Rollercoaster Ride
Looking at the last few months, ACHC has been on a noticeable downtrend. Back in late February, it was trading around $40. Then, in a sharp move, it plunged to the low $30s by the end of February. After that, it mostly hovered in the $28-$30 range through March.
April brought more declines, with the stock dipping into the mid-$20s and even hitting a 52-week low of $20.36 around April 21st. Since then, it's seen a bit of a rebound, climbing back into the $22-$26 range. The last recorded price was $22.53 on May 23rd.
So, the overall trend has been down, but there's been some recent stabilization and even a slight bounce from its lows. The current price of $22.53 is significantly lower than where it was a few months ago, but it's also above its recent bottom.
What's the Outlook? Mixing Signals and Potential Plays
Putting it all together, we've got some interesting signals. The analyst price target cuts are a bit of a dampener, suggesting a more conservative view from the pros. However, the stock has already taken a significant hit, and it's showing some signs of finding a floor.
AIPredictStock.com's AI model offers a more optimistic view for the very near term. It predicts a 0.00% change for today, followed by a 2.00% increase tomorrow, and a 3.15% rise the day after. This suggests the AI sees some upward momentum building. The AI also highlights strong buying pressure (volume 4.1x average) and positive news sentiment with high confidence, which is a good sign.
Given the stock's recent bounce from its lows and the AI's short-term positive outlook, the situation might lean towards a potential buying opportunity for those with a medium-term horizon (1-3 months), especially if you're a value investor. The stock is trading very close to a support level ($22.53), which could be a good entry point.
- Potential Entry Consideration: If you're considering getting in, a price around the current $22.57 to $22.71 range could be interesting. This aligns with the identified support level and the AI's short-term positive prediction.
- Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss order around $20.28 might make sense. This is just below the recent 52-week low, giving the stock some room to move but protecting against further significant drops. On the upside, the AI projects an upward trend with a potential target of $1.01 (likely a percentage gain, not an absolute dollar value, given the context), and analysts have an average target of $42.86, suggesting significant room to grow if the sentiment shifts. A short-term take-profit could be considered around $22.98, based on the AI's immediate projections.
Company Context: Healthcare's Foundation
Remember, Acadia Healthcare is a major player in behavioral healthcare, operating facilities across the U.S. and Puerto Rico. They have a large employee base (25,500 full-time staff). The healthcare sector can be quite stable, but it's also subject to regulatory changes and broader economic conditions. While the company's revenue growth has been low (0.3%) and debt is a bit high (Debt-to-Equity at 74.09%), the P/E ratio at 11.0x is in a neutral range. The core business of providing mental health and recovery services remains a critical need.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.
相关新闻
Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $32
Mizuho analyst Ann Hynes maintains Acadia Healthcare Co with a Neutral and lowers the price target from $37 to $32.
Barclays Maintains Equal-Weight on Acadia Healthcare Co, Lowers Price Target to $28
Barclays analyst Andrew Mok maintains Acadia Healthcare Co with a Equal-Weight and lowers the price target from $35 to $28.
Keybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $55
Keybanc analyst Matthew Gillmor maintains Acadia Healthcare Co with a Overweight and lowers the price target from $65 to $55.
AI预测Beta
AI建议
更新于: 2025年6月13日 00:48
61.9% 置信度
风险与交易
入场点
$22.21
止盈点
$22.57
止损点
$19.92
关键因素
相关股票
保持更新
设置价格提醒,获取AI分析更新和实时市场新闻。